These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 21163532)

  • 1. Disruption of the alternative pathway convertase occurs at the staphylococcal surface via the acquisition of factor H by Staphylococcus aureus.
    Sharp JA; Cunnion KM
    Mol Immunol; 2011 Jan; 48(4):683-90. PubMed ID: 21163532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into the Effects of Complement Factor H on the Assembly and Decay of the Alternative Pathway C3 Proconvertase and C3 Convertase.
    Bettoni S; Bresin E; Remuzzi G; Noris M; Donadelli R
    J Biol Chem; 2016 Apr; 291(15):8214-30. PubMed ID: 26903516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staphylococcus aureus surface protein SdrE binds complement regulator factor H as an immune evasion tactic.
    Sharp JA; Echague CG; Hair PS; Ward MD; Nyalwidhe JO; Geoghegan JA; Foster TJ; Cunnion KM
    PLoS One; 2012; 7(5):e38407. PubMed ID: 22675461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staphylococcal Ecb protein and host complement regulator factor H enhance functions of each other in bacterial immune evasion.
    Amdahl H; Jongerius I; Meri T; Pasanen T; Hyvärinen S; Haapasalo K; van Strijp JA; Rooijakkers SH; Jokiranta TS
    J Immunol; 2013 Aug; 191(4):1775-84. PubMed ID: 23863906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cleavage of complement C3b to iC3b on the surface of Staphylococcus aureus is mediated by serum complement factor I.
    Cunnion KM; Hair PS; Buescher ES
    Infect Immun; 2004 May; 72(5):2858-63. PubMed ID: 15102797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The extracellular adherence protein from Staphylococcus aureus inhibits the classical and lectin pathways of complement by blocking formation of the C3 proconvertase.
    Woehl JL; Stapels DAC; Garcia BL; Ramyar KX; Keightley A; Ruyken M; Syriga M; Sfyroera G; Weber AB; Zolkiewski M; Ricklin D; Lambris JD; Rooijakkers SHM; Geisbrecht BV
    J Immunol; 2014 Dec; 193(12):6161-6171. PubMed ID: 25381436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A molecular insight into complement evasion by the staphylococcal complement inhibitor protein family.
    Ricklin D; Tzekou A; Garcia BL; Hammel M; McWhorter WJ; Sfyroera G; Wu YQ; Holers VM; Herbert AP; Barlow PN; Geisbrecht BV; Lambris JD
    J Immunol; 2009 Aug; 183(4):2565-74. PubMed ID: 19625656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitor.
    Rooijakkers SH; Wu J; Ruyken M; van Domselaar R; Planken KL; Tzekou A; Ricklin D; Lambris JD; Janssen BJ; van Strijp JA; Gros P
    Nat Immunol; 2009 Jul; 10(7):721-7. PubMed ID: 19503103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Factor H-Fc fusion protein increases complement-mediated opsonophagocytosis and killing of community associated methicillin-resistant Staphylococcus aureus.
    Sage MAG; Cranmer KD; Semeraro ML; Ma S; Galkina EV; Tran Y; Wycoff KL; Sharp JA
    PLoS One; 2022; 17(3):e0265774. PubMed ID: 35324969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor H binding as a complement evasion mechanism for an anaerobic pathogen, Fusobacterium necrophorum.
    Friberg N; Carlson P; Kentala E; Mattila PS; Kuusela P; Meri S; Jarva H
    J Immunol; 2008 Dec; 181(12):8624-32. PubMed ID: 19050282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement regulator C4BP binds to Staphylococcus aureus and decreases opsonization.
    Hair PS; Wagner SM; Friederich PT; Drake RR; Nyalwidhe JO; Cunnion KM
    Mol Immunol; 2012 Apr; 50(4):253-61. PubMed ID: 22333221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of vaccinia virus complement control protein with human complement proteins: factor I-mediated degradation of C3b to iC3b1 inactivates the alternative complement pathway.
    Sahu A; Isaacs SN; Soulika AM; Lambris JD
    J Immunol; 1998 Jun; 160(11):5596-604. PubMed ID: 9605165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tick-over theory revisited: formation and regulation of the soluble alternative complement C3 convertase (C3(H2O)Bb).
    Bexborn F; Andersson PO; Chen H; Nilsson B; Ekdahl KN
    Mol Immunol; 2008 Apr; 45(8):2370-9. PubMed ID: 18096230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hijacking Factor H for Complement Immune Evasion.
    Moore SR; Menon SS; Cortes C; Ferreira VP
    Front Immunol; 2021; 12():602277. PubMed ID: 33717083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of peptidic inhibitors of the alternative complement pathway based on Staphylococcus aureus SCIN proteins.
    Summers BJ; Garcia BL; Woehl JL; Ramyar KX; Yao X; Geisbrecht BV
    Mol Immunol; 2015 Oct; 67(2 Pt B):193-205. PubMed ID: 26052070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Capsule production and growth phase influence binding of complement to Staphylococcus aureus.
    Cunnion KM; Lee JC; Frank MM
    Infect Immun; 2001 Nov; 69(11):6796-803. PubMed ID: 11598052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum complement factor I decreases Staphylococcus aureus phagocytosis.
    Cunnion KM; Buescher ES; Hair PS
    J Lab Clin Med; 2005 Nov; 146(5):279-86. PubMed ID: 16242527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human factor H-related protein 5 has cofactor activity, inhibits C3 convertase activity, binds heparin and C-reactive protein, and associates with lipoprotein.
    McRae JL; Duthy TG; Griggs KM; Ormsby RJ; Cowan PJ; Cromer BA; McKinstry WJ; Parker MW; Murphy BF; Gordon DL
    J Immunol; 2005 May; 174(10):6250-6. PubMed ID: 15879123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular basis for complement recognition and inhibition determined by crystallographic studies of the staphylococcal complement inhibitor (SCIN) bound to C3c and C3b.
    Garcia BL; Ramyar KX; Tzekou A; Ricklin D; McWhorter WJ; Lambris JD; Geisbrecht BV
    J Mol Biol; 2010 Sep; 402(1):17-29. PubMed ID: 20654625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A humanized antibody that regulates the alternative pathway convertase: potential for therapy of renal disease associated with nephritic factors.
    Paixão-Cavalcante D; Torreira E; Lindorfer MA; Rodriguez de Cordoba S; Morgan BP; Taylor RP; Llorca O; Harris CL
    J Immunol; 2014 May; 192(10):4844-51. PubMed ID: 24729617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.